Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Walsh Elizabeth L.Director | Open-market purchase | BUY | $120K 4,575 sh | May 7, 2026 |
| 36 | Deegan Brian JohnGroup Chief Accounting Officer | Open-market sale | SELL | $338K 11.0K sh | May 7, 2026 traded May 5, 2026 |
| 36 | Campbell Renee LSVP, Capital Markets & Risk | Open-market sale | SELL | $215K 412 sh | May 7, 2026 traded May 6, 2026 |
| 36 | Norsa MicheleDirector | Open-market sale | SELL | $47K 4,000 sh | May 7, 2026 traded May 5, 2026 |
| 36 | Guo Jack Q.EVP & CFO | Open-market sale | SELL | $822K 25.2K sh | May 7, 2026 traded May 5, 2026 |
| 30 | Chan MitchellDirector | Open-market sale · 10b5-1 plan | SELL | $72K 3,167 sh | May 7, 2026 traded May 6, 2026 |
| 30 | Brown Claude LeonardChief Business Officer | Open-market sale | SELL | $1.27M 61.0K sh | May 7, 2026 traded May 6, 2026 |
| 29 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $426K 19.0K sh | May 7, 2026 traded May 6, 2026 |
| 29 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $953K 44.9K sh | May 7, 2026 traded May 6, 2026 |
| 28 | Jaime CesarDirector | Open-market sale | SELL | $123K 10.0K sh | May 7, 2026 traded May 5, 2026 |
| 28 | Robin Jodi F.General Counsel and Secretary | Open-market sale | SELL | $123K 3,000 sh | May 7, 2026 traded May 5, 2026 |
| 26 | Eldessouky SamEVP and CFO | Tax withholding | F | $1.02M 63.9K sh | May 7, 2026 traded May 5, 2026 |
| 26 | Gallagher Thomas P.Director, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $756K 15.8K sh | May 7, 2026 traded May 5, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $201K 8,900 sh | May 7, 2026 traded May 6, 2026 |
| 26 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $230K 10.1K sh | May 7, 2026 traded May 6, 2026 |
| 25 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $496K 27.5K sh | May 7, 2026 traded May 6, 2026 |
| 25 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $257K 13.8K sh | May 7, 2026 traded May 6, 2026 |
| 25 | Neagle MatthewChief Operating Officer | Open-market sale | SELL | $634K 60.8K sh | May 7, 2026 traded May 5, 2026 |
| 24 | Robin Jodi F.General Counsel and Secretary | Open-market sale | SELL | $83K 2,000 sh | May 7, 2026 traded May 7, 2026 |
| 23 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $47K 15.0K sh | May 7, 2026 traded May 6, 2026 |
| 22 | Bruggeworth Robert ADirector, President and CEO | Tax withholding | F | $1.63M 17.6K sh | May 7, 2026 traded May 5, 2026 |
| 22 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $197K 9,219 sh | May 7, 2026 traded May 6, 2026 |
| 22 | Guggina David WExecutive Vice President | Tax withholding | F | $1.21M 9,247 sh | May 7, 2026 traded May 5, 2026 |
| 22 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $238K 12.3K sh | May 7, 2026 traded May 6, 2026 |
| 22 | Canup Edward GCHIEF BANKING OFFICER | Open-market purchase | BUY | $20K 1,000 sh | May 7, 2026 traded May 5, 2026 |
| 22 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $111K 10.6K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Zamudio-Ramirez PavelChief Customer Officer | Option exercise | M | — 2,935 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Hunt Bradley WilliamDirector | Grant or award | A | — 20.8K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Heller John E.Director, Chief Executive Officer | Option exercise | M | — 18.1K sh | May 7, 2026 traded May 6, 2026 |
| 21 | Natan DavidDirector | Grant or award | A | — 100.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Guivisdalsky Deborah FridaChief Operating Officer | Grant or award | A | — 7,000 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Rodriguez Robles Yaiza MariaGC & Secretary of the BOD | Grant or award | A | — 7,000 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Sher AvivChief Executive Officer | Grant or award | A | — 30.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Priebe DavidDirector | Grant or award | A | — 4,929 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Hagy James BrentChief Legal Officer&CorpSec(1) | Grant or award | A | — 1,850 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Viana Antonio JDirector | Open-market sale · 10b5-1 plan | SELL | $601K 20.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Bruning Jill LChief Technology Officer | Option exercise | M | — 9,072 sh | May 7, 2026 traded May 6, 2026 |
| 21 | Mullen Sean ThomasChief Growth Officer | Option exercise | M | — 9,072 sh | May 7, 2026 traded May 6, 2026 |
| 21 | Jones RamonDirector | Grant or award | A | — 20.8K sh | May 7, 2026 traded May 5, 2026 |
| 19 | Brown GrantSVP & Chief Financial Officer | Tax withholding | F | $388K 4,194 sh | May 7, 2026 traded May 5, 2026 |